Welcome to the e-CCO Library!

P308: Safety of the given patency capsule in patients with Crohn's disease or suspected Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva M., Cardoso H., Peixoto A., Nunes A.C.-R., Marques M., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P308: Utility of bowel ultrasound in diagnosing disease activity in Crohn’s disease: Indian experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Kakkadasam Ramaswamy*1, K. V. Nagarajan1, A. Yelsangikar1, A. Nagar1, N. Bhat1

Created: Friday, 22 February 2019, 9:41 AM
P309 Ferritin or transferrin saturation vs. soluble transferrin receptor for iron deficiency diagnosis in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. DAUDE1, T. Remen2, T. Chateau3, S. Danese4, I. Gastin5, C. Baumann6, J.L. Gueant5, L. Peyrin-Biroulet1

Created: Thursday, 30 January 2020, 10:12 AM
P309: Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bacsur, P.(1)*;Wetwittayakhlang, P.(2);Resál, T.(1);Rutka, M.(1);Bessissow, T.(2);Atif, W.(2);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);Lakatos, P.L.(2,3);Molnár, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P309: Are results from VARSITY applicable to real world? Adalimumab versus vedolizumab as first line biological in moderate-to-severe IBD.
Year: 2021
Source: ECCO'21 Virtual
Authors: Moens, A.(1,2);Verstockt, B.(1,2);Alsoud, D.(2);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P309: Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn’s disease recurrence
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Cerrillo1*, I. Moret2, M. Iborra1, D. Hervás3, L. Tortosa1, E. Sáez-González1, P. Nos1, B. Beltrán1

Created: Thursday, 21 February 2019, 9:14 AM
P309: High infliximab trough levels are associated with better control of inflammation in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Drobne*1, T. Kurent1, P. Rajar2, M. Slak3, M. Kozelj1, G. Novak1, N. Smrekar1, S. Plut1, A. Smid1, J. Osredkar4, B. Stabuc1, I. Ferkolj1

Created: Friday, 22 February 2019, 9:49 AM
P309: Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1,2, G. Bastida3,4, A. Forés5, E. García-Planella6, F. Argüelles-Arias7, P. Sarasa8, I. Tagarro8, A. Fernández-Nistal8, C. Montoto8, M. Aguas3,4, J. Santos-Fernández9, M. Boscá10, R. Ferreiro-Iglesias11, O. Merino12, X. Aldeguer13, X. Cortés14,15, B. Sicilia16, F. Mesonero17, M. Barreiro-de Acosta11

Created: Friday, 22 February 2019, 9:41 AM
P309: Impact of rapid access MR on clinical decision making and patient management in Crohn's disease in a tertiary referral center
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lovasz B.D.*1, Gonczi L.1, Kurti Z.1, Vegh Z.1, Golovics P.A.1, Rudas G.2, Gecse K.B.1, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P309: Withdrawal of thiopurines in Inflammatory Bowel Disease patients in stable remission: a prospective, multicentre cohort study
Year: 2022
Source: ECCO'22
Authors: Savelkoul, E.(1);Mahmoud, R.(2);De Jong, D.(1);Van Dop, W.(1);Römkens, T.(3);Nissen, L.(3);Mahmmod, N.(4);Van Boeckel, P.(4);Lutgens, M.(5);Mares, W.(6);Epping, L.(7);Minderhoud, I.(8);Jansen, J.(9);Gisbertz, I.(10);Boekema, P.(11);De Koning, D.(12);Horjus, C.(13);Jharap, B.(14);Oldenburg, B.(2);Hoentjen, F.(15);
Created: Friday, 11 February 2022, 3:52 PM
P310 The efficacy of linked colour imaging, a novel endoscopic enhancement system, for diagnosing mucosal redness in ulcerative colitis patients in clinical remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Takagi1, K. Uchiyama1, M. Kajiwara1, Y. Azuma1, S. Takayama1, R. Yasuda1, K. Inoue1, H. Ryohei1, O. Dohi1, N. Yoshida1, K. Kamada1, T. Ishikawa1, N. Yagi2, Y. Naito1, Y. Itoh1

Created: Thursday, 30 January 2020, 10:12 AM
P310: Atopic dermatitis is associated with the clinical course of Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Kim, K.W.(1);Ha, H.(2);Jun, Y.(1);Lee, H.J.(1);Yoon, H.(3);Kang, H.W.(4);Im, J.P.(1);Kim, J.S.(1);Koh, S.J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P310: Automated digital calculation of endoscopic inflammation in ulcerative colitis: Results of the red density study
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Bossuyt1,2*, H. Nakase3, S. Vermeire1, H. Willekens1, Y. Ikemoto4, T. Makino4, R. Bisschops1

Created: Thursday, 21 February 2019, 9:14 AM
P310: Development of a new clinico-biological score associated with disease activity in patients with inflammatory bowel disease treated with thiopurine
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Williet N.*1, Nancey S.2, Boureille A.3, Altwegg R.4, Cadiot G.5, Nachury M.6, Laharie D.7, Filippi J.8, Sparrow M.9, Nahon S.10, Bouguen G.11, Aygalenq P.12, Viennot S.13, Bonnaud G.14, Dupin M.15, Boukhadra N.15, Del Tedesco E.16, Roblin X.16

Created: Wednesday, 20 February 2019, 10:36 AM
P310: Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Vernero*1, D. G. Ribaldone1, M. Astegiano1

Created: Friday, 22 February 2019, 9:41 AM
P310: Is ileoanal pouch excision a destination therapy for Inflammatory Bowel Disease? Data from a quaternary pouch referral center
Year: 2021
Source: ECCO'21 Virtual
Authors: Choi, S.(1);Lightner, A.(1);Lipman, J.(1);Hull, T.(1);Steele, S.(1);Holubar, S.(1);Rieder, F.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P310: Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Irving*1, C. Probert2, D. R. Gaya3, P. J. Hamlin4, S. Sebastian5, G. Gillespie6, H. Tate6, C. Wheeler6

Created: Friday, 22 February 2019, 9:49 AM
P310: Smoking is not an independent risk factor for surgery in patients with Crohn's Disease on biologic therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sharara, A.(1)*;Halablab, S.(1);Sadaka, C.(1);Slika, H.(1);Adra, N.(1);Ghusn, W.(1);Shmeis, M.(1);Al Razim, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P311 Detection and characterisation of extra-intestinal manifestations of IBD in clinical office notes using natural language processing
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Stidham1,2,3, D. Yu4, S. Lahiri4, V. Vydiswaran4

Created: Thursday, 30 January 2020, 10:12 AM
P311: Crohn’s disease: What can we expect from the course of the disease?
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Arieira1,2,3*, T. Cúrdia Gonçalves1,2,3, F. Dias de Castro1,2,3, M.J. Moreira1,2,3, J. Cotter1,2,3

Created: Thursday, 21 February 2019, 9:14 AM